Clinical Trial

Voll Degradable Shoulder Spacer FIH Study

Recruiting
View on ClinicalTrials.gov →
Summary
The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-28; most recent amendment 2026-03-05.
Status change: Not Yet Recruiting → Recruiting 2026-01-15
Trial Details
NCT Number NCT07208448
Lead Sponsor Voll Medical Technologies Ltd.
Conditions Massive Rotator Cuff Tear
Enrollment 20 participants
Start Date 2025-12-09
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30